TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32388522

Group type: EXPERIMENTAL
Intervention: Laser therapy (diode laser, λ: 645 nm) administered for three consecutive days starting on day 1 (T0)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham therapy (placebo)
Number of subjects: 60
Study: 34993836

Group type: EXPERIMENTAL
Intervention: Home-based high-intensity interval training (HIIT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Home-based moderate-intensity continuous training (MICT)
Number of subjects: 21
Study: 32574096

Group type: EXPERIMENTAL
Intervention: Virtual Boxing Group (VBG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Real Boxing Group (RBG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 40
Study: 35257166

Group type: EXPERIMENTAL
Intervention: Multiple nursing interventions (group training, counselling, reminder phone calls, delivery materials)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 134
Study: 35512252

Group type: EXPERIMENTAL
Intervention: Rosuvastatin, 10 mg daily
Number of subjects: 2733

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2733

Group type: EXPERIMENTAL
Intervention: Cholestanol-to-cholesterol ratio (3rd vs. 1st tertile)
Number of subjects: 2733

Group type: EXPERIMENTAL
Intervention: Lathosterol-to-cholesterol ratio (3rd vs. 1st tertile)
Number of subjects: 2733
Study: 33904823

Group type: EXPERIMENTAL
Intervention: Nurse-led, home-based heart failure self-management program (HOM-HEMP)
Number of subjects: 11
Study: 35582748

Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) 50-200 mg/day
Number of subjects: 738

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 738
Study: 33653749

Group type: EXPERIMENTAL
Intervention: WeChat‐VRT group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 50
Study: 32580710

Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet (FMD) plus usual care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FMD plus usual care
Number of subjects: 100
Study: 35012310

Group type: EXPERIMENTAL
Intervention: PS-GOS-enriched beverage (2 g PS/day and 4.3 g GOS/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PS-enriched beverage (2 g PS/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both beverages (PS and PS-GOS)
Number of subjects: 0
Study: 33306213

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: CNS involvement
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: No CNS disease
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Elevated IPI score and CNS disease
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 160
Study: 32211084

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 0
Study: 34875850

Group type: EXPERIMENTAL
Intervention: Viable allogeneic disc tissue supplementation
Number of subjects: 218

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 218
Study: 32228635

Group type: EXPERIMENTAL
Intervention: Isotonic sport drink (SPD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Skim milk (SM)
Number of subjects: 9
Study: 36254073

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Desflurane anesthesia
Number of subjects: 36
Study: 34918714

Group type: EXPERIMENTAL
Intervention: Aloe ferox (460 mg, 2 capsules/day for 2 weeks, followed by a 2-week break, repeated 3 times)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (diet only)
Number of subjects: 20
Study: 32894102

Group type: EXPERIMENTAL
Intervention: HIV-1-positive women, treatment-naive, tested for transmitted drug resistance mutations (TDRM)
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: Israeli-born women
Number of subjects: 763

Group type: COMPARATOR
Intervention: Women diagnosed between 2010-2012
Number of subjects: 763

Group type: COMPARATOR
Intervention: Women diagnosed between 2016-2018
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: Overall trend
Number of subjects: 763
Study: 34861767

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 0
Study: 34523108

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCC); median dose 1,000 units
Number of subjects: 415

Group type: COMPARATOR
Intervention: Frozen plasma (FP); median dose 4 units
Number of subjects: 415
Study: 36137670

Group type: EXPERIMENTAL
Intervention: LBBP‐CRT
Number of subjects: 40
Study: 33303389

Group type: EXPERIMENTAL
Intervention: Nightly sildenafil 50 mg and sildenafil 100 mg on demand for sexual relations (up to 6 pills/month)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Nightly sildenafil 50 mg (5 nights/week) plus intracavernosal injections twice/week
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nightly placebo with sildenafil 100 mg on demand for sexual relations (up to 6 pills/month)
Number of subjects: 76
Study: 34626526

Group type: EXPERIMENTAL
Intervention: Bedaquiline (BDQ)
Number of subjects: 429
Study: 36655300

Group type: EXPERIMENTAL
Intervention: semaglutide 2.4 mg
Number of subjects: 174

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 174
Study: 33563758

Group type: EXPERIMENTAL
Intervention: Bot accounts identifying as Democratic or Republican, varying in strength of identification.
Number of subjects: 842
Study: 32591103

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active surveillance (no maintenance therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy with 10% discount
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy with 20% discount
Number of subjects: 0
Study: 35395952

Group type: EXPERIMENTAL
Intervention: Closed-loop automated oxygen control (CLAC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual oxygen control
Number of subjects: 70
Study: 34287530

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) therapy
Number of subjects: 18
Study: 32717350

Group type: EXPERIMENTAL
Intervention: Adaptive preventive intervention (API) designed to educate and motivate heavy-drinking college students; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive preventive intervention (API); specific details on dosage and duration not available.
Number of subjects: 0
Study: 36096312

Group type: EXPERIMENTAL
Intervention: Molecular point-of-care testing (mPOCT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (routine clinical care)
Number of subjects: 200
Study: 34129708

Group type: EXPERIMENTAL
Intervention: ARP using demineralized bovine bone mineral containing 10% collagen (DBBM-C) covered by a collagen matrix (CM) (n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ARP using demineralized bovine bone mineral containing 10% collagen (DBBM-C) covered with a palatal graft (PG) (n=25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Spontaneous healing (control) (n=25)
Number of subjects: 75
Study: 33934677

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Theory of Planned Behavior (TPB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (nonintervention condition)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 30
Study: 32133391

Group type: EXPERIMENTAL
Intervention: Standardized, telephone‐based lifestyle intervention (diet, physical activity, behavior) with 19 calls over 2 years
Number of subjects: 338

Group type: COMPARATOR
Intervention: Mail‐based educational material alone (control)
Number of subjects: 338
Study: 35411792

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 758
Study: 36149735

Group type: EXPERIMENTAL
Intervention: eHealth lifestyle coaching program
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 340
Study: 32172425

Group type: EXPERIMENTAL
Intervention: Ganglion plexus ablation
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study: 32792107

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus small changes lifestyle intervention
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 139
Study: 35086535

Group type: EXPERIMENTAL
Intervention: In‐Service Teacher Training (INSETT) combined with Teaching Recovery Techniques (TRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer Integration and Enhancement Resources (PIER)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 0
Study: 32107930

Group type: EXPERIMENTAL
Intervention: Insulin Degludec/Liraglutide (IDegLira)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal-Bolus (BB) therapy (once-daily insulin glargine 100 U/mL and insulin aspart ≤4 times/day)
Number of subjects: 0
Study: 616172268

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CB-G2)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Radiofrequency current (RFC) ablation
Number of subjects: 34
Study: 36227782

Group type: EXPERIMENTAL
Intervention: Linaclotide 290 μg
Number of subjects: 2350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2350
Study: 33306104

Group type: EXPERIMENTAL
Intervention: Aortic valve calcification
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Mitral valve calcification
Number of subjects: 1769
Study: 32623059

Group type: EXPERIMENTAL
Intervention: Immersive tutorial in virtual reality (VR) as a teaching supplement
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no immersive tutorial)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Immersive tutorial in virtual reality (VR)
Number of subjects: 176
Study: 36085103

Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Fetal position
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (conventional peripheral vascular access without extra intervention)
Number of subjects: 148
Study: 33878115

Group type: EXPERIMENTAL
Intervention: Chikungunya virus (CHIKV) seroprevalence
Number of subjects: 1981

Group type: COMPARATOR
Intervention: Living conditions
Number of subjects: 1981

Group type: EXPERIMENTAL
Intervention: Population density
Number of subjects: 1981
Study: 33217593

Group type: EXPERIMENTAL
Intervention: Tamoxifen combined with toremifene treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Toremifene
Number of subjects: 100
Study: 37536514

Group type: EXPERIMENTAL
Intervention: 10 kHz spinal cord stimulation plus conventional medical management (10 kHz SCS+CMM)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Conventional medical management (CMM) alone
Number of subjects: 216
Study: 33542348

Group type: EXPERIMENTAL
Intervention: Cumulative incidence of diabetes
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Raw incidence rate
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Undiagnosed cases among incident cases
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Risk factors associated with diabetes
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Predictive value of risk factors
Number of subjects: 517
Study: 32664643

Group type: EXPERIMENTAL
Intervention: Teaching Games for Understanding (TGfU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Direct Instruction (DI)
Number of subjects: 30
Study: 35834373

Group type: EXPERIMENTAL
Intervention: Screening strategy with machine learning risk prediction algorithm and diagnostic testing
Number of subjects: 334993

Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 334993
Study: 33272311

Group type: EXPERIMENTAL
Intervention: Standard physical therapy plus battlefield acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard physical therapy
Number of subjects: 0
Study: 33964569

Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained MS (MSt)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained HC (HCt)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained MS (MSt) and trained HC (HCt)
Number of subjects: 29

Group type: COMPARATOR
Intervention: untrained MS (MSu)
Number of subjects: 29

Group type: COMPARATOR
Intervention: untrained HC (HCu)
Number of subjects: 29
Study: 32608120

Group type: EXPERIMENTAL
Intervention: Listening to recorded mother's voice via headphones
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wearing headphones without auditory stimuli (Control)
Number of subjects: 127
Study: 35754036

Group type: EXPERIMENTAL
Intervention: Lowest SES group
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Screen time (hours)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Childcare attendance
Number of subjects: 306

Group type: COMPARATOR
Intervention: Childcare duration (years)
Number of subjects: 306
Study: 32691141

Group type: EXPERIMENTAL
Intervention: Modified Abbreviated Burn Severity Index (mABSI)
Number of subjects: 2296
Study: 34942595

Group type: EXPERIMENTAL
Intervention: High calcium pre-exercise meals (1,000 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low calcium pre-exercise meals (<50 mg)
Number of subjects: 16
Study: 32377858

Group type: EXPERIMENTAL
Intervention: VITOM® system with VERSACRANE™ holding system
Number of subjects: 22

Group type: COMPARATOR
Intervention: VITOM® system with ARTip™ cruise holding system
Number of subjects: 22
Study: 33839130

Group type: COMPARATOR
Intervention: Moderate-risk patients
Number of subjects: 4262

Group type: COMPARATOR
Intervention: High-risk patients
Number of subjects: 4262
Study: 34706268

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention provided by dental professionals
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention with power-brush
Number of subjects: 538

Group type: COMPARATOR
Intervention: Standard oral hygiene advice (control)
Number of subjects: 538
Study: 32307033

Group type: EXPERIMENTAL
Intervention: Pre-hospital emergency anaesthesia (PHEA) provided by UK Helicopter Emergency Medical Services (HEMS)
Number of subjects: 20
Study: 34534233

Group type: EXPERIMENTAL
Intervention: Aceclofenac 100mg
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Etoricoxib 90mg
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Xanthine oxidase inhibitors
Number of subjects: 384
Study: 33065552

Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin
Number of subjects: 339

Group type: COMPARATOR
Intervention: clopidogrel/aspirin
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin (carriers)
Number of subjects: 339

Group type: COMPARATOR
Intervention: clopidogrel/aspirin (carriers)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin (non-carriers)
Number of subjects: 339

Group type: COMPARATOR
Intervention: clopidogrel/aspirin (non-carriers)
Number of subjects: 339
Study: 36165907

Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (WMT), adaptive training, n = 28 PWH; nonadaptive training, n = 25 PWH; 25 sessions over 5–8 weeks.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Nonadaptive training, n = 23 SN.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Adaptive WMT
Number of subjects: 106
Study: 34051134

Group type: EXPERIMENTAL
Intervention: Low FODMAPs diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual dietary advice
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study: 32022618

Group type: EXPERIMENTAL
Intervention: Terbinafine hydrochloride spray (THS) in combination with 3% boric acid alcohol (3% BAA) ear drops
Number of subjects: 320

Group type: COMPARATOR
Intervention: 3% boric acid alcohol (3% BAA) ear drops
Number of subjects: 320
Study: 616826658

Group type: EXPERIMENTAL
Intervention: Structural word puzzles
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Semantic/thematic word puzzles
Number of subjects: 53

Group type: COMPARATOR
Intervention: Daily diary control group
Number of subjects: 53
Study: 35406083

Group type: EXPERIMENTAL
Intervention: Anti-meal (low inflammatory potential)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Neutr-meal (moderate inflammatory potential)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pro-meal (high inflammatory potential)
Number of subjects: 11
Study: 33709238

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) involving triple rehabilitation therapy (electro‐acupuncture, Chinese medicinal herb fumigating‐washing, and traditional exercises)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Conventional rehabilitation therapy (physical factor therapy, joint movement training, and muscle strength training)
Number of subjects: 696
Study: 32758474

Group type: EXPERIMENTAL
Intervention: Liver transplantation after tumor downstaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36187365

Group type: EXPERIMENTAL
Intervention: 12-week online multicomponent stress reduction intervention including yoga, breathwork, meditation videos, cognitive behavioral therapy activities, and check-ins.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group received weekly motivational messages by email.
Number of subjects: 101
Study: 33278859

Group type: EXPERIMENTAL
Intervention: Fibrin glue injection with combination therapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Fibrin glue injection without combination therapy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Fibrin glue injection (overall population)
Number of subjects: 119
Study: 34323681

Group type: EXPERIMENTAL
Intervention: lenabasum 5 mg twice daily
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: lenabasum 20 mg twice daily
Number of subjects: 365

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 365
Study: 32066487

Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gyejibongnyeong-Hwan (GBH) after 8 weeks of controlled waiting
Number of subjects: 40
Study: 35416465

Group type: EXPERIMENTAL
Intervention: 1000mg metamizole + 400mg ibuprofen
Number of subjects: 35
Study: 33962504

Group type: EXPERIMENTAL
Intervention: Immature poken extract (IPE)
Number of subjects: 20
Study: 33609324

Group type: EXPERIMENTAL
Intervention: Assessment of drug treatment quality by three specialist physicians and two resident physicians
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Assessment of the association between drug treatment and hospital admission
Number of subjects: 30
Study: 32842975

Group type: EXPERIMENTAL
Intervention: Standardised and individually adapted exercise intervention (12 weeks of biweekly exercise including aerobic and strengthening exercises)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Standardised and individually adapted exercise intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral and written information about a home-based exercise programme (Control)
Number of subjects: 120
Study: 35100776

Group type: EXPERIMENTAL
Intervention: Cognitive Aid (CA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-Cognitive Aid (non-CA)
Number of subjects: 0
Study: 34264860

Group type: EXPERIMENTAL
Intervention: Acupuncture plus normal dose of Chinese herbal fumigation steam therapy (CHFST)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acupuncture plus one-sixteenth of a normal dose of CHFST
Number of subjects: 42

Group type: COMPARATOR
Intervention: Acupuncture only (Control group)
Number of subjects: 42
Study: 35218194

Group type: EXPERIMENTAL
Intervention: Sugar reduction intervention (goal of ≤10% of calories from free sugar) for 12 weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (standard dietary advice)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sugar reduction intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Participants with whole-body fat mass (FM) reduction (irrespective of randomization)
Number of subjects: 105
Study: 33523081

Group type: EXPERIMENTAL
Intervention: Tapered-tip toothbrush
Number of subjects: 70

Group type: COMPARATOR
Intervention: End-rounded toothbrush
Number of subjects: 70
Study: 36306128

Group type: EXPERIMENTAL
Intervention: Narrative-based psychoeducational intervention (8-week program with nurse-led interactive video sessions)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Didactic education (4 nurse-led sessions)
Number of subjects: 608
Study: 34148146

Group type: EXPERIMENTAL
Intervention: HIIT (4 × 3 min at 90% VO2max interspersed with 3 min at 60% VO2max)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: VICT (25 min at 70% VO2max)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: VICT
Number of subjects: 29
Study: 34330860

Group type: EXPERIMENTAL
Intervention: Shorter study duration, fewer prompts, shorter prompts, and higher compensation
Number of subjects: 600

Group type: COMPARATOR
Intervention: Intensive study design features (longer duration, more prompts, longer prompts, lower compensation)
Number of subjects: 600
Study: 33109190

Group type: EXPERIMENTAL
Intervention: STAND+ (multilevel intervention with sit-stand workstations)
Number of subjects: 630

Group type: COMPARATOR
Intervention: MOVE+ (multilevel intervention targeting reduction in sedentary time and increases in light physical activity)
Number of subjects: 630
Study: 35125265

Group type: EXPERIMENTAL
Intervention: Group-based therapy (GT)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Email-delivered self-help cognitive behavioral therapy (ESH)
Number of subjects: 135
Study: 34129709

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Pessary
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cerclage
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Combination of treatments
Number of subjects: 255